Our semaglutide pill is a high-purity pharmaceutical grade peptide developed for research applications. This GLP-1 receptor agonist demonstrates significant potential in metabolic disorder studies.
The semaglutide pill formulation shows dual agonist activity at both GLP-1 and GIP receptors, making it particularly valuable for diabetes and obesity research. Clinical studies have demonstrated its effectiveness in glucose control and weight management applications.
Key research applications include: metabolic syndrome studies, diabetes treatment research, obesity management investigations, and pancreatic function analysis. The semaglutide pill formulation offers extended half-life compared to native peptides.
Our production follows strict GMP standards to ensure batch-to-batch consistency. The white lyophilized powder format provides excellent stability and convenient reconstitution properties for laboratory use.
Important Note: This product is supplied for research purposes only. Not for human consumption. Proper laboratory handling procedures should always be followed when working with peptide compounds.